Targeting antibacterial agents by using drug-carrying filamentous bacteriophages - Wikidata - wikimedia - TriplyDB

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

http://www.wikidata.org/entity/Q24548258

about

Killing cancer cells by targeted drug-carrying phage nanomedicines Targeted drug-carrying bacteriophages as antibacterial nanomedicines Genetically Engineered Phages: a Review of Advances over the Last Decade Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.Hybrid nanoparticles for detection and treatment of cancer Chemical strategies for the covalent modification of filamentous phage Display technologies: application for the discovery of drug and gene delivery agents.Landscape phage ligands for PC3 prostate carcinoma cells Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening.Identification of methicillin-resistant Staphylococcus aureus-specific peptides for targeted photoantimicrobial chemotherapy.Bacteriophage-based synthetic biology for the study of infectious diseases.Viral nanoparticles as platforms for next-generation therapeutics and imaging devices Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro.Chemical modulation of M13 bacteriophage and its functional opportunities for nanomedicine.Applications of viral nanoparticles in medicine.Targeting glioblastoma via intranasal administration of Ff bacteriophages.In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines Evolution of phage display technology: from discovery to application.Novel approaches to developing new antibiotics for bacterial infections.Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics Antibacterial nanomedicine.What are the limitations on the wider therapeutic use of phage?Design of virus-based nanomaterials for medicine, biotechnology, and energy.M13 virus based detection of bacterial infections in living hosts.Using viruses as nanomedicines.Functionalization of protein-based nanocages for drug delivery applications.Molecular and chemical engineering of bacteriophages for potential medical applications.Mammalian synthetic biology: emerging medical applications.Chemically Modifying Viruses for Diverse Applications.Phages targeting infected tissues: novel approach to phage therapy.Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics.Chemical coupling as a potent strategy for preparation of targeted bacteriophage-derived gene nanocarriers into eukaryotic cells.Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectives.Translocation Pathway-Dependent Assembly of Streptavidin- and Antibody-Binding Filamentous Virus-Like Particles.Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.Real-time femtomolar detection of cancer biomarkers from photoconjugated antibody-phage constructs.

P2860

Q21256651-E1030827-6EAB-4BFD-97D8-0390A0A0BD70 Q24673452-ADB345AC-6E91-41BF-8EAD-8B8CD83B752F Q26744156-11B947CA-9D3C-426C-976A-C3B41AFD0B32 Q26795483-F6CDA941-64E8-47FD-AD21-2DE5C3557255 Q26849404-48AD8C26-78EC-4355-875E-3E53FD43DA2A Q26992196-B0E023DA-1FF5-4E74-BB68-3DEDE40CCB8B Q33264491-4C9FD02E-4B45-4ADD-A032-6E2D803C8B2D Q33534585-E74EF9AD-6EAB-405F-83C3-7650653DDC93 Q33566182-8DF51320-9F8B-49DB-801D-9EC35FDE6514 Q33779010-F8982456-7BEC-4682-AED9-072B8F88CE10 Q34017160-54F3DCC8-B51C-46CD-B92B-2B1691CC2213 Q34168677-CCE36AF0-2586-48FF-B25E-7B3317850798 Q34291876-5E834615-02B9-499A-BF63-1D1C8ED9B92B Q34653188-080593F3-27B2-4B8E-8F1F-342E7ECC48B5 Q34731688-28D67E72-986A-42F6-A314-B57E08398CD6 Q35501007-24A831E8-F2B6-4C41-A9CE-7A4493CB9F72 Q35651275-A8526651-68F5-42C4-8049-3E0389819258 Q35763456-6A70E4BB-8992-4E34-A880-F9A9E3293F94 Q36183954-2DDFAA8B-E71A-4F79-9F98-B7FF410DA6EF Q36358643-E08B9366-2E40-41A7-B5EA-AB9AFE690513 Q36652581-ADB2123F-8FA2-48C2-A750-F65AF52B84F7 Q36758570-A947CB4F-1E69-4C50-BBEE-634AE4FD3D3D Q37087480-A0310946-4DE4-4AE7-8FD4-165EEC8CA6DF Q37176392-39738B0F-394A-4E9A-97AB-D0B606E79530 Q37291441-9AE89ED2-B4AF-41CF-B18D-BC65E2052434 Q37346447-1B127150-B69C-463C-8FEF-59B80C5F0237 Q37707198-F7B76D8B-8CD4-4FCB-B29E-A71F7D1BC602 Q38191282-60FB2F28-5D63-4F52-BEB4-F64F140691A9 Q38214775-CD3F87FD-977B-4AF2-827E-F4DF3015AA60 Q38232491-5961C430-2D06-4F2E-B9E1-9FAB8006430C Q38390803-FBFD5919-C18A-4564-B92A-7276DBB9336F Q38756361-01C2D7FD-A81D-43E8-91C0-4203F8B88E68 Q39037957-F3B62B2A-D382-4D2B-8940-BA5C00D14244 Q39414836-4397A2E2-4DC1-424E-9DCC-9F20C3DD0425 Q39457287-7E940AF7-9980-460D-A84A-E0ACAFE5F9F5 Q39690702-37E58200-597E-42A2-9D94-4D98311FB039 Q40529713-7DAFDEDB-6249-488F-BD80-B35FA0DF9510 Q47298251-C16C47AF-3173-4A97-A3F6-FC3182E328C0 Q48013238-9D4521F5-AC30-4F0A-B1F5-1C5E6C77B99F

P2860

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

http://www.wikidata.org/entity/Q24548258

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@ast

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@en

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@nl

type

label

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@ast

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@en

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@nl

prefLabel

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@ast

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@en

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@nl

P1433

Q24548258-CDF123F4-9382-4736-AD2A-7410D6CF2794

P1476

Q24548258-46B28C79-4109-49A3-9960-D4F5B8EA353B

P2093

Q24548258-072319DD-0D4D-4A14-A1D4-4E1688405F63

Q24548258-48F4D543-34A1-4168-8638-BC27DCA31895

Q24548258-57D792A5-F0DA-4E10-86C9-C4D513B26178

Q24548258-652B184D-40B9-44B7-9F88-4740890AF3BA

Q24548258-A0C61564-DCAC-4C38-88E5-918A0E9BB60F

P2860

Q24548258-010D412B-2108-470C-A134-7A46ADF271F1

Q24548258-0474D2C8-491A-4A53-BF50-EA43F7F7E292

Q24548258-0497CC2A-F55D-4220-8DF1-EAF69A0C469B

Q24548258-053D4B6F-29CF-4D23-9D97-F80BD3C3154E

Q24548258-100B661C-E37C-4373-82E8-5F218C6AEE37

Q24548258-13EFC5B1-2BE2-4476-9FFB-5A544C3E2C6A

Q24548258-17B5A192-9CCD-459E-B5B1-7535C57298F2

Q24548258-18CFC039-DE93-4904-89A9-99B30BF188E7

Q24548258-1BB785DE-4B98-44DD-A7DC-A6DB94A9CEC3

Q24548258-1C825427-9118-47FD-9D25-C624D00472DE

P304

Q24548258-BF1774CB-0003-4603-8A2F-FDB3389F149C

P31

Q24548258-98BF3D83-12A9-453F-8935-91CA1F9AA571

P356

Q24548258-5A09A1BD-6A6C-4A03-888B-33016C1FBBA1

P407

Q24548258-DA772E5E-E9A5-4844-9FF1-515D7411D349

P433

Q24548258-91474E53-2919-4B35-B26B-4801BE6DBEE8

P478

Q24548258-7667860A-33C5-4C1B-AD93-4E23771373BA

P577

Q24548258-D7911AC7-4DDD-447A-A4DF-7E94DCAEB7D9

P5875

Q24548258-D8EC5361-6E51-4239-9677-B8C83DEDB511

P698

Q24548258-519C5C09-244C-408B-809E-34ADC2A66075

P921

Q24548258-086AFF93-2955-46B3-BD21-1CF5A19CE534

Q24548258-5207A6F7-72EA-4FEA-9822-BBEEB9DF174A

P932

Q24548258-274162B9-919D-447D-8787-B4CC5E98A150

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

@en

P2093

Doron Shabat

http://www.w3.org/2001/XMLSchema#string

Hagit Bar

http://www.w3.org/2001/XMLSchema#string

Iftach Yacoby

http://www.w3.org/2001/XMLSchema#string

Itai Benhar

http://www.w3.org/2001/XMLSchema#string

Marina Shamis

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous cultures of fused cells secreting antibody of predefined specificity

Staphylococcus aureus infections

Biotechnological applications of phage and cell display

PEGylation, successful approach to drug delivery

Prevention and control of methicillin-resistant Staphylococcus aureus infections.

Phage display of a cellulose binding domain from Clostridium thermocellum and its application as a tool for antibody engineering.

Uptake and processing of modified bacteriophage M13 in mice: implications for phage display

Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA' fusions on live bacteria.

The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd.

A visualization method of filamentous phage infection and phage-derived proteins in Escherichia coli using biotinylated phages.

P304

2087-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00169-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7058465

http://www.w3.org/2001/XMLSchema#string

P698

16723570

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

1479106

http://www.w3.org/2001/XMLSchema#string